Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Supportive care

M Markman1

  • 1Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, OH 44195, USA.

Cancer Chemotherapy and Biological Response Modifiers
|January 1, 1996
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences in Discounting Behavior and Brain Responses for Food and Money Reward.

eNeuro·2024
Same author

Apical hypertrophic cardiomyopathy: A case series at a Brazilian referral center with a maximal follow-up of 15 years.

Annales de cardiologie et d'angeiologie·2021
Same author

Platinum-Gemcitabine-Avastin (PGA) for platinum-resistant/refractory ovarian cancer.

European journal of gynaecological oncology·2018
Same author

Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach.

Current oncology (Toronto, Ont.)·2018
Same author

Surgical intervention in relapsed ovarian cancer is beneficial: contra.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

The use of bevacizumab in the management of ovarian cancer: an argument for single-agent rather than combination therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same journal

Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanoma.

Cancer chemotherapy and biological response modifiers·2005
Same journal

Human tumor associated antigen mimicry by xenoantigens, anti-idiotypic antibodies and peptide mimics: implications for immunotherapy of malignant diseases.

Cancer chemotherapy and biological response modifiers·2005
Same journal

DNA vaccines for melanoma.

Cancer chemotherapy and biological response modifiers·2005
Same journal

Immunizing against partially defined antigen mixtures, gangliosides, or peptides to induce antibody, T cell, and clinical responses.

Cancer chemotherapy and biological response modifiers·2005
Same journal

Chemotherapy, cytokines, and biochemotherapy for melanoma.

Cancer chemotherapy and biological response modifiers·2005
Same journal

Current status of interferon-alpha in the treatment of melanoma.

Cancer chemotherapy and biological response modifiers·2005
See all related articles